2 Rheumatology Unit, The Queen Elizabeth Hospital, Woodville Rd, Woodville, South Australia, Australia Correspondence to: Dr C L Hill Rheumatology Unit, The Queen Elizabeth Hospital, Woodville Road, ...

The approval marks the first new treatment option for people living with progressive pulmonary fibrosis (PPF) in more than five years. PPF is a rare lung condition, more life-threatening than many ...

Background: Survival of scleroderma has changed since the renal crisis treatment has become possible. Aims: To document the changes in survival and organ system causes of mortality in systemic ...

Tomisa Starr has spent most of her life battling health issues, but she has never let it stop her from living. In 1993, she was diagnosed with scleroderma, a rare autoimmune disease that causes the ...

ABSTRACT: Objective: Study of severe visceral damage in systemic scleroderma in the rheumatology Department of CHU de Cocody. Patients and Methods: We conducted a retrospective descriptive study of ...

Investigational interstitial lung disease (ILD) drug, efzofitimod, shows early signs of efficacy in patients with pulmonary sarcoidosis and SSc-ILD (scleroderma-related ILD), according to new trial ...

Respiratory and pulmonary conditions can be complex, often misunderstood, and may even go undiagnosed for years. Having lived with the rare autoimmune disorder scleroderma since I was 19, I started ...

Patients with systemic sclerosis who have lipodermatosclerosis vs those without lipodermatosclerosis have a higher rate of cardiac arrhythmia, heart failure, and pulmonary hypertension.

Background: Right ventricular (RV) contractile reserve is a main determinant of outcome in pulmonary arterial hypertension (PAH). PAH and RV maladaptation are common and portend a poor prognosis in ...

ABSTRACT: Purpose: Studies on imaging findings in mixed connective tissue disease (MCTD) are limited. This study assessed the relationship between CT-derived parameters (pulmonary artery diameter [PAD ...